Up a level |
2022
Subbiah, Vivek, Wolf, Jurgen, Konda, Bhavana, Kang, Hyunseok, Spira, Alexander, Weiss, Jared, Takeda, Masayuki, Ohe, Yuichiro, Khan, Saad, Ohashi, Kadoaki, Soldatenkova, Victoria, Szymczak, Sylwia, Sullivan, Loretta, Wright, Jennifer and Drilon, Alexander (2022). Tumour-agnostic efficacy and safety of selpercatinib in patients with RET fusion-positive solid tumours other than lung or thyroid tumours (LIBRETTO-001): a phase 1/2, open-label, basket trial. Lancet Oncol., 23 (10). S. 1261 - 1274. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1474-5488
2021
Skoulidis, Ferdinandos, Li, Bob T., Dy, Grace K., Price, Timothy J., Falchook, Gerald S., Wolf, Jurgen, Italiano, Antoine, Schuler, Martin, Borghaei, Hossein, Barlesi, Fabrice, Kato, Terufumi, Curioni-Fontecedro, Alessandra ORCID: 0000-0002-5778-5270, Sacher, Adrian ORCID: 0000-0001-7865-2701, Spira, Alexander, Ramalingam, Suresh S., Takahashi, Toshiaki, Besse, Benjamin, Anderson, Abraham, Ang, Agnes, Tran, Qui ORCID: 0000-0002-0760-964X, Mather, Omar, Henary, Haby, Ngarmchamnanrith, Gataree, Friberg, Gregory, Velcheti, Vamsidhar and Govindan, Ramaswamy (2021). Sotorasib for Lung Cancers with KRAS p.G12C Mutation. N. Engl. J. Med., 384 (25). S. 2371 - 2382. WALTHAM: MASSACHUSETTS MEDICAL SOC. ISSN 1533-4406
2015
Camidge, Ross, Cappuzzo, Federico, Go, Jowell, Isaacson, Jeffrey, Litten, Jason, Park, Keunchil, Spigel, David R., Spira, Alexander, Vergnenegre, Alain, Wolf, Juergen, Yang, James Chih-Hsin and Mok, Tony (2015). TIGER-1: A Phase 2/3 Study of First Line Rociletinib or Erlotinib in EGFR-Mutant NSCLC. J. Thorac. Oncol., 10 (9). S. S427 - 1. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1556-1380